Back to search
Blasts 5 Percent or More of Bone Marrow Nucleated Cells
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Blasts 5 Percent or More of Bone Marrow Nucleated Cells trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Blasts 5 Percent or More of Bone Marrow Nucleated Cells trials you may qualify forThis phase I trial studies best dose and side effects of liposome-encapsulated daunorubicin-cytarabine (CPX-351) and how well it works in treating patients with…
This phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders.
This phase I/II trial studies the side effects and best dose of ADCT-602 in treating patients with B-cell lymphoblastic leukemia that has come back or does not…
This phase I clinical trial studies the side effects and best dose of CD19-specific T-cells in treating patients with lymphoid malignancies that have spread to…
This phase Ib/II trial studies side effects and best dose of inotuzumab ozogamicin and how well it works when given together with vincristine sulfate liposome i…